Page last updated: 2024-08-16

thalidomide and medroxyprogesterone

thalidomide has been researched along with medroxyprogesterone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Lenz, W1
Contu, P; Dessì, M; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Serpe, R1
Mantovani, G1

Reviews

2 review(s) available for thalidomide and medroxyprogesterone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Forms and causes of human malformations.
    Acta morphologica Academiae Scientiarum Hungaricae, 1980, Volume: 28, Issue:1-2

    Topics: Abnormalities, Drug-Induced; Congenital Abnormalities; Estrogens; Fanconi Anemia; Female; Genes, Dominant; Genes, Recessive; Gestational Age; Humans; Medroxyprogesterone; Pregnancy; Progesterone; Thalidomide

1980

Trials

2 trial(s) available for thalidomide and medroxyprogesterone

ArticleYear
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
    The oncologist, 2010, Volume: 15, Issue:2

    Topics: Appetite Stimulants; Cachexia; Carnitine; Eicosapentaenoic Acid; Female; Humans; Interleukin-6; Male; Medroxyprogesterone; Megestrol Acetate; Middle Aged; Neoplasms; Thalidomide; Vitamin B Complex

2010
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
    European review for medical and pharmacological sciences, 2010, Volume: 14, Issue:4

    Topics: Aged; Body Composition; Cachexia; Carnitine; Contraceptives, Oral, Hormonal; Eicosapentaenoic Acid; Endpoint Determination; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone; Megestrol; Middle Aged; Motor Activity; Neoplasms; Prognosis; Thalidomide

2010